Clinical studies in patients with obesity have revealed that mutations in leptin, pro-opiomelanocortin (POMC), and melanocortin 4 receptor (MC4R) are positively associated with hyperphagia, hyperinsulinemia, and excessive adiposity (29–34). Here, POMC is linked to obesity disorder.